Literature DB >> 18586996

Indicators of conformance with guidelines of schizophrenia treatment in mental health services.

Paola Bollini1, Sandro Pampallona, Salvatore Nieddu, Maurizio Bianco, Giuseppe Tibaldi, Carmine Munizza.   

Abstract

OBJECTIVE: The aim of this study was to develop indicators of conformance in clinical practice with guidelines for care in schizophrenia. Recommended guidelines rarely apply to all patients and need to allow for social ability, family context, and phase of the disorder. These indicators were therefore devised for tailoring to patient characteristics and allowing for factors that may justify the lack of adherence to clinical guidelines.
METHODS: A team of senior clinicians and methodologists reviewed three clinical guidelines (from the Schizophrenia Patient Outcomes Research Team, McEvoy and colleagues, and the National Institute for Health and Clinical Excellence) and defined criteria for their operationalization into clinical indicators. For each indicator, the team defined criteria for eligibility (requirements to be met to qualify for evaluation), conformance (criteria to be satisfied to comply with each recommendation), and moderators (factors that could justify the lack of application of a given recommendation). These indicators were tested with a random sample of 807 patients with schizophrenia or schizoaffective disorders in outpatient facilities, long-term residential facilities, and hospital units for acute care in the Piedmont region of Italy.
RESULTS: A set of 15 indicators was derived, nine concerning pharmacological treatment and six for general care and psychosocial rehabilitation. Moderators such as patient or family refusal of antipsychotic treatment and the patient's level of disability helped to justify a considerable proportion of nonconformant care.
CONCLUSIONS: The indicators developed are a simple and useful tool to monitor the conformance of care with recommended practices and to identify areas needing improvement.

Entities:  

Mesh:

Year:  2008        PMID: 18586996     DOI: 10.1176/ps.2008.59.7.782

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  10 in total

1.  Powerful choices: peer support and individualized medication self-determination.

Authors:  Corinna West
Journal:  Schizophr Bull       Date:  2009-06-10       Impact factor: 9.306

2.  Call for information, call for quality in mental health care.

Authors:  A Lora
Journal:  Epidemiol Psychiatr Sci       Date:  2012-12-18       Impact factor: 6.892

3.  Quality of care indicators for schizophrenia: determinants of observed variations among Italian Departments of Mental Health. Results from the ETAS DSM study.

Authors:  G Fantini; G Tibaldi; P Rucci; D Gibertoni; M Vezzoli; L Cifarelli; R Tiraferri; C Munizza
Journal:  Epidemiol Psychiatr Sci       Date:  2016-03-28       Impact factor: 6.892

4.  A conditional model of evidence-based decision making.

Authors:  Paul R Falzer; Melissa D Garman
Journal:  J Eval Clin Pract       Date:  2009-12       Impact factor: 2.431

5.  Nonconformance probability of an air quality index.

Authors:  Tsai-Yu Lin; Chen-Tuo Liao; Yen-Ya Liao
Journal:  J Appl Stat       Date:  2019-11-14       Impact factor: 1.416

6.  Attention to irrelevant cues is related to positive symptoms in schizophrenia.

Authors:  Richard Morris; Oren Griffiths; Michael E Le Pelley; Thomas W Weickert
Journal:  Schizophr Bull       Date:  2012-01-20       Impact factor: 9.306

7.  Performance indicators for public mental healthcare: a systematic international inventory.

Authors:  Steve Lauriks; Marcel Ca Buster; Matty As de Wit; Onyebuchi A Arah; Niek S Klazinga
Journal:  BMC Public Health       Date:  2012-03-20       Impact factor: 3.295

8.  Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume.

Authors:  S G Fillman; T W Weickert; R K Lenroot; S V Catts; J M Bruggemann; V S Catts; C S Weickert
Journal:  Mol Psychiatry       Date:  2015-07-21       Impact factor: 15.992

9.  Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder.

Authors:  Danny Boerrigter; Thomas W Weickert; Rhoshel Lenroot; Maryanne O'Donnell; Cherrie Galletly; Dennis Liu; Martin Burgess; Roxanne Cadiz; Isabella Jacomb; Vibeke S Catts; Stu G Fillman; Cynthia Shannon Weickert
Journal:  J Neuroinflammation       Date:  2017-09-18       Impact factor: 8.322

10.  Common polymorphisms in dopamine-related genes combine to produce a 'schizophrenia-like' prefrontal hypoactivity.

Authors:  A Vercammen; C S Weickert; A J Skilleter; R Lenroot; P R Schofield; T W Weickert
Journal:  Transl Psychiatry       Date:  2014-02-04       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.